Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Ngoc T Hoang, Luis A Acevedo, Michael J Mann & Bhairavi Tolani. (2018) A review of soft-tissue sarcomas: translation of biological advances into treatment measures. Cancer Management and Research 10, pages 1089-1114.
Read now
Read now
Hans Gelderblom, Ian R. Judson, Charlotte Benson, Ofer Merimsky, Giovanni Grignani, Daniela Katz, Klaus W. Freivogel, Dara Stein, Minesh Jobanputra, Arron Mungul, Stephanie C. Manson & Roberta Sanfilippo. (2017) Treatment patterns and clinical outcomes with pazopanib in patients with advanced soft tissue sarcomas in a compassionate use setting: results of the SPIRE study. Acta Oncologica 56:12, pages 1769-1775.
Read now
Read now
Rick L. M. Haas, Hans Gelderblom, Stefan Sleijfer, Hester H. van Boven, Astrid Scholten, Luc Dewit, Gerben Borst, Jos van der Hage, J. Martijn Kerst, Remi A. Nout, Henk H. Hartgrink, Ilse de Pree, Cornelis Verhoef, Neeltje Steeghs & Frits van Coevorden. (2015) A phase I study on the combination of neoadjuvant radiotherapy plus pazopanib in patients with locally advanced soft tissue sarcoma of the extremities. Acta Oncologica 54:8, pages 1195-1201.
Read now
Read now
Articles from other publishers (31)
Surya K. De. 2023. Medicines for Cancer. Medicines for Cancer
205
411
.
Wenda Huang, Zhaonian Hao, Feng Mao & Dongsheng Guo. (2022) Small Molecule Inhibitors in Adult High-Grade Glioma: From the Past to the Future. Frontiers in Oncology 12.
Crossref
Crossref
Sotirios Papadopoulos, Pantelis Koulouris, Claire Royer-Chardon, Georgia Tsoumakidou, Ana Dolcan, Stephane Cherix, Maurice Matter, Patrick Omoumi & Antonia Digklia. (2022) Case Report: Tyrosine Kinase Inhibitors Induced Lymphadenopathy in Desmoid Tumor Patients. Frontiers in Endocrinology 13.
Crossref
Crossref
Satoshi Narahara, Katsuya NagaokaMasakuni Tateyama, Hideaki Miyamoto, Kentaro Tanaka, Takayuki Tokunaga, Takeshi Kawasaki, Yoko Yoshimaru, Takehisa Watanabe, Hiroko Setoyama, Hideaki Naoe, Motohiko Tanaka, Yutaka Sasaki & Yasuhito Tanaka. (2021) A case of primary hepatic leiomyosarcoma treated with multi-line chemotherapy多次化学療法を施行した原発性肝平滑筋肉腫の一例. Kanzo 62:9, pages 538-547.
Crossref
Crossref
Eman Z. Elrazaz, Rabah A.T. Serya, Nasser S.M. Ismail, Amgad Albohy, Dalal A. Abou El Ella & Khaled A.M. Abouzid. (2021) Discovery of potent thieno[2,3-d]pyrimidine VEGFR-2 inhibitors: Design, synthesis and enzyme inhibitory evaluation supported by molecular dynamics simulations. Bioorganic Chemistry 113, pages 105019.
Crossref
Crossref
Haruchika Yamamoto, Hiromasa Yamamoto, Junichi Soh, Etsuji Suzuki, Kei Namba, Ken Suzawa, Kentaroh Miyoshi, Shinji Otani, Mikio Okazaki, Seiichiro Sugimoto, Masaomi Yamane, Takashi Yorifuji, Katsuhito Takahashi & Shinichi Toyooka. (2020) A Simple Prognostic Benefit Scoring System for Sarcoma Patients with Pulmonary Metastases: Sarcoma Lung Metastasis Score. Annals of Surgical Oncology 28:7, pages 3884-3890.
Crossref
Crossref
Sen Liu, Xu Chen & Tianxin Lin. (2021) Lymphatic metastasis of bladder cancer: Molecular mechanisms, diagnosis and targeted therapy. Cancer Letters 505, pages 13-23.
Crossref
Crossref
Kentaro Miyake, Takashi Higuchi, Hiromichi Oshiro, Zhiying Zhang, Norihiko Sugisawa, Jun Ho Park, Sahar Razmjooei, Yuki Katsuya, Maryam Barangi, Yunfeng Li, Scott D. Nelson, Takashi Murakami, Yuki Homma, Yukihiko Hiroshima, Ryusei Matsuyama, Michael Bouvet, Sant P. Chawla, Shree Ram Singh, Itaru Endo & Robert M. Hoffman. (2019) The combination of gemcitabine and docetaxel arrests a doxorubicin-resistant dedifferentiated liposarcoma in a patient-derived orthotopic xenograft model. Biomedicine & Pharmacotherapy 117, pages 109093.
Crossref
Crossref
Roser Pons-Cursach & Oriol Casanovas. 2019. Tumor Angiogenesis. Tumor Angiogenesis
183
208
.
Iratxe Zuazo-Gaztelu & Oriol Casanovas. (2018) Unraveling the Role of Angiogenesis in Cancer Ecosystems. Frontiers in Oncology 8.
Crossref
Crossref
Hyojeong Choi & Aree Moon. (2018) Crosstalk between cancer cells and endothelial cells: implications for tumor progression and intervention. Archives of Pharmacal Research 41:7, pages 711-724.
Crossref
Crossref
Andrew W. Brown. 2018.
55
107
.
Dinesh Kumar Chellappan, Jestin Chellian, Zhao Yin Ng, Yan Jinn Sim, Chiu Wei Theng, Joyce Ling, Mei Wong, Jia Hui Foo, Goh Jun Yang, Li Yu Hang, Saranyah Nathan, Yogendra Singh & Gaurav Gupta. (2017) The role of pazopanib on tumour angiogenesis and in the management of cancers: A review. Biomedicine & Pharmacotherapy 96, pages 768-781.
Crossref
Crossref
Frank Peinemann, Heike Enk & Lesley A Smith. (2017) Autologous hematopoietic stem cell transplantation following high-dose chemotherapy for nonrhabdomyosarcoma soft tissue sarcomas. Cochrane Database of Systematic Reviews 2018:7.
Crossref
Crossref
A. Marcell Szász, Balázs Győrffy & György Marko-Varga. (2017) Cancer heterogeneity determined by functional proteomics. Seminars in Cell & Developmental Biology 64, pages 132-142.
Crossref
Crossref
Roser Pons-Cursach & Oriol Casanovas. 2017. Tumor Angiogenesis. Tumor Angiogenesis
1
25
.
Oriol Casanovas & Roser Pons-Cursach. 2017. Tumor Angiogenesis. Tumor Angiogenesis
1
25
.
Sandro Pasquali, Antonella Brunello, Alessandro Gronchi, Samuel J Ford, Marco Maruzzo, Marco Rastrelli & Simone Mocellin. (2016) First- and second-line systemic treatments for metastatic and locally advanced soft tissue sarcomas in adults. Cochrane Database of Systematic Reviews.
Crossref
Crossref
C. Llacer-Moscardo, C. Bourgier, A. Morel, P. Fenoglietto, S. Carrère, N. Firmin & D. Azria. (2016) Radiothérapie des sarcomes des tissus mous des membres : évolution technique et impact sur le bénéfice clinique. Cancer/Radiothérapie 20:6-7, pages 666-676.
Crossref
Crossref
Darci M. Fink, Maria M. Steele & Michael A. Hollingsworth. (2016) The lymphatic system and pancreatic cancer. Cancer Letters 381:1, pages 217-236.
Crossref
Crossref
Rick L.M. Haas, Aisha B. Miah, Cécile LePechoux, Thomas F. DeLaney, Elizabeth H. Baldini, Kaled Alektiar & Brian O’Sullivan. (2016) Preoperative radiotherapy for extremity soft tissue sarcoma; past, present and future perspectives on dose fractionation regimens and combined modality strategies. Radiotherapy and Oncology 119:1, pages 14-21.
Crossref
Crossref
Yasuhiro Yoshimatsu, Hideki Miyazaki & Tetsuro Watabe. (2016) Roles of signaling and transcriptional networks in pathological lymphangiogenesis. Advanced Drug Delivery Reviews 99, pages 161-171.
Crossref
Crossref
Diane-Charlotte Imbs, Marie-Noelle Paludetto, Sylvie Négrier, Helen Powell, Thierry Lafont, Melanie White-Koning, Etienne Chatelut & Fabienne Thomas. (2015) Determination of unbound fraction of pazopanib in vitro and in cancer patients reveals albumin as the main binding site. Investigational New Drugs 34:1, pages 41-48.
Crossref
Crossref
Parag P. Patwardhan, Kathryn S. Ivy, Elgilda Musi, Elisa de Stanchina & Gary K. Schwartz. (2015) Significant blockade of multiple receptor tyrosine kinases by MGCD516 (Sitravatinib), a novel small molecule inhibitor, shows potent anti-tumor activity in preclinical models of sarcoma. Oncotarget 7:4, pages 4093-4109.
Crossref
Crossref
Xiaoxia Zhu & Wen Zhou. (2015) The Emerging Regulation of VEGFR-2 in Triple-Negative Breast Cancer. Frontiers in Endocrinology 6.
Crossref
Crossref
Jiho Song, Jakyung Yoo, Ara Kwon, Doran Kim, Hong Khanh Nguyen, Bong-Yong Lee, Wonhee Suh & Kyung Hoon Min. (2015) Structure-Activity Relationship of Indole-Tethered Pyrimidine Derivatives that Concurrently Inhibit Epidermal Growth Factor Receptor and Other Angiokinases. PLOS ONE 10:9, pages e0138823.
Crossref
Crossref
Andreas du BoisAnne FloquetJae-Weon KimJoern RauJosep M. del CampoMichael FriedlanderSandro PignataKeiichi FujiwaraIgnace VergoteNicoletta ColomboMansoor R. MirzaBradley J. MonkRainer KimmigIsabelle Ray-CoquardRongyu ZangIvan Diaz-PadillaKlaus H. BaumannMarie-Ange Mouret-ReynierJae-Hoon KimChristian KurzederAnne LesoinPaul VaseyChristian MarthUlrich CanzlerGiovanni ScambiaMuneaki ShimadaPaula CalvertEric Pujade-LauraineByoung-Gie KimThomas J. HerzogIonel MitricaCarmen Schade-BrittingerQiong WangRocco CrescenzoPhilipp Harter. (2014) Incorporation of Pazopanib in Maintenance Therapy of Ovarian Cancer. Journal of Clinical Oncology 32:30, pages 3374-3382.
Crossref
Crossref
P. Wong, P. Houghton, D. G. Kirsch, S. E. Finkelstein, A. M. Monjazeb, M. Xu-Welliver, A. P. Dicker, M. Ahmed, B. Vikram, B. A. Teicher, C. N. Coleman, M. Machtay, W. J. Curran & D. Wang. (2014) Combining Targeted Agents With Modern Radiotherapy in Soft Tissue Sarcomas. JNCI Journal of the National Cancer Institute 106:11, pages dju329-dju329.
Crossref
Crossref
Diane-Charlotte Imbs, Sylvie Négrier, Philippe Cassier, Antoine Hollebecque, Andrea Varga, Ellen Blanc, Thierry Lafont, Bernard Escudier, Jean-Charles Soria, David Pérol & Etienne Chatelut. (2014) Pharmacokinetics of pazopanib administered in combination with bevacizumab. Cancer Chemotherapy and Pharmacology 73:6, pages 1189-1196.
Crossref
Crossref
Steven A. Stacker, Steven P. Williams, Tara Karnezis, Ramin Shayan, Stephen B. Fox & Marc G. Achen. (2014) Lymphangiogenesis and lymphatic vessel remodelling in cancer. Nature Reviews Cancer 14:3, pages 159-172.
Crossref
Crossref
Caroline P. Le, Tara Karnezis, Marc G. Achen, Steven A. Stacker & Erica K. Sloan. (2013) Lymphovascular and neural regulation of metastasis: Shared tumour signalling pathways and novel therapeutic approaches. Best Practice & Research Clinical Anaesthesiology 27:4, pages 409-425.
Crossref
Crossref